Urology · Natick, MA
NPI
1285807560
Since 2008
Specialty
Urology
Code 208800000X
Group practices
2
Medicare group memberships
Hospitals
2
Hospital affiliations
67 Union St Ste 308
Natick, MA, 01760
Phone (508) 655-4422
Groups this clinician bills Medicare through
Medicare paid, 2024
$369K
19,406 services
Medicare patients, 2024
674
Average age 75
Drug cost, 2024
$572K
2,512 prescriptions
Company payments, 2025
$1,894
From 22 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Ravi Kacker was code J1071 (injection, testosterone cypionate, 1 mg), 10,900 times for 12 patients. In total Ravi Kacker billed 19,406 services in 89 codes, and Medicare paid $369K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2026-01-30.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J1071 Injection, testosterone cypionate, 1 mg | Office | 10,900 | 12 | $0.02 | $208 |
| 51798 Ultrasound - Nonspecific | Office | 726 | 430 | $9.62 | $6,984 |
| 36415 Venipuncture Blood Collection | Office | 710 | 387 | $8.65 | $6,142 |
| 81000 Clinical Chemistry | Office | 663 | 398 | $3.93 | $2,603 |
| 99214 Office E&M - Established | Office | 615 | 379 | $97.11 | $60K |
| 84153 Clinical Chemistry | Office | 610 | 365 | $18.02 | $11K |
| J0696 Injection, ceftriaxone sodium, per 250 mg | Office | 480 | 99 | $0.36 | $172 |
| 99213 Office E&M - Established | Office | 458 | 324 | $71.74 | $33K |
| 84403 Clinical Chemistry | Office | 331 | 170 | $25.29 | $8,371 |
| 84270 Clinical Chemistry | Office | 300 | 155 | $21.30 | $6,390 |
| 81001 Clinical Chemistry | Office | 286 | 239 | $3.11 | $889 |
| 85018 Blood Count | Office | 285 | 142 | $2.32 | $661 |
| 76770 Ultrasound - Abdomen and Pelvis | Office | 214 | 99 | $45.42 | $9,720 |
| 76775 Ultrasound - Abdomen and Pelvis | Office | 212 | 98 | $24.80 | $5,258 |
| 96372 Injection Administration | Office | 177 | 112 | $12.51 | $2,214 |
By year: 2022 $390K for 34,017 services; 2023 $366K for 27,683 services; 2024 $369K for 19,406 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 710 | 387 | $8.65 | $6,142 |
| 81000 Clinical Chemistry | 663 | 398 | $3.93 | $2,603 |
| 84153 Clinical Chemistry | 610 | 365 | $18.02 | $11K |
| 84403 Clinical Chemistry | 331 | 170 | $25.29 | $8,371 |
| 84270 Clinical Chemistry | 300 | 155 | $21.30 | $6,390 |
| 81001 Clinical Chemistry | 286 | 239 | $3.11 | $889 |
| 85018 Blood Count | 285 | 142 | $2.32 | $661 |
| 84443 Clinical Chemistry | 32 | 29 | $16.46 | $527 |
Medicare prescription drug claims, 2024
In 2024, the drug Ravi Kacker prescribed most often to Medicare patients was Testosterone Cypionate, with 465 prescriptions and refills. In total Ravi Kacker wrote 2,512 Medicare prescriptions that cost $572K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Testosterone Cypionate Generic | 465 | 483 | 81 | $14K |
| Tamsulosin Hcl Generic | 278 | 712 | 89 | $4,703 |
| Alfuzosin Hcl Er Alfuzosin Hcl | 246 | 606 | 83 | $5,706 |
| Myrbetriq Mirabegron | 163 | 235 | 39 | $105K |
| Oxybutynin Chloride Er Oxybutynin Chloride | 131 | 285 | 49 | $3,472 |
| Cabergoline Generic | 128 | 266 | 30 | $10K |
| Gemtesa Vibegron | 122 | 229 | 38 | $108K |
| Finasteride Generic | 93 | 217 | 32 | $1,506 |
| Nitrofurantoin Nitrofurantoin Macrocrystal | 84 | 146 | 35 | $2,133 |
| Testosterone Generic | 81 | 82 | 18 | $18K |
| Estradiol Generic | 63 | 144 | 27 | $4,796 |
| Chlorthalidone Generic | 57 | 156 | 18 | $1,301 |
| Sulfamethoxazole-Trimethoprim Sulfamethoxazole/Trimethoprim | 48 | 48 | 39 | $189 |
| Nitrofurantoin Mono-Macro Nitrofurantoin Monohyd/M-Cryst | 45 | 45 | 35 | $449 |
| Oxybutynin Chloride Generic | 39 | 65 | 13 | $536 |
Brand drugs: 425 claims; generic drugs: 2,087 claims; opioid claims: 27.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Ravi Kacker $1,894 ($1,894 in general payments such as food, travel and fees) from 22 companies. The largest payer was Procept Biorobotics Corporation with $368.
| Company | Payments | Amount |
|---|---|---|
| Procept Biorobotics Corporation PRCT | 8 | $368 |
| Janssen Biotech, Inc. JNJ | 6 | $252 |
| Endo USA, Inc. | 8 | $242 |
| Ferring Pharmaceuticals Inc. | 6 | $156 |
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 4 | $100 |
| Tolmar, Inc. | 3 | $81.07 |
| Teleflex LLC TFX | 3 | $80.35 |
| Boston Scientific Corporation BSX | 3 | $65.23 |
| Immunitybio, Inc. IBRX | 2 | $61.38 |
| Myriad Genetic Laboratories, Inc. MYGN | 3 | $60.31 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.